Clinical trials
Recruiting Phase 2 Melanoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 10 |
| 2024 | 10 |
| 2025 | 18 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Innovent Biologics (Suzhou) Co. Ltd. | 3 |
| National Cancer Institute (NCI) | 3 |
| Sun Yat-sen University | 3 |
| Grupo Español Multidisciplinar de Melanoma | 2 |
| Mayo Clinic | 2 |
| Melanoma Institute Australia | 2 |
| NYU Langone Health | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| University of California, Irvine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 70 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Brain Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Lung Neoplasms | 7 |
| Breast Neoplasms | 6 |
| Carcinoma, Renal Cell | 6 |
| Pancreatic Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Carcinoma, Hepatocellular | 5 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.